Albemarle Corporation ALB

109.73 1.48 1.37% as of 25 Sep
Market cap
$12.9B
P/E
229×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years

Albemarle Corporation (ALB) EBITDA

Albemarle Corporation's EBITDA for fiscal 2025 was $472.7M, compared with −$1.2B in fiscal 2024. Over the twelve months to 30 June 2026 it was $1.1B. Over the past ten years it has ranged from −$1.2B (fiscal 2024) to $2.8B (fiscal 2022); the current reading is higher than 18% of that period. Albemarle Corporation ranks 11th of 59 Specialty Chemicals companies by EBITDA.

EBITDA, annual

Annual

Period EBITDA Change
FY2025 $472.7M —
FY2024 −$1.2B —
FY2023 $681.8M (75.39%)
FY2022 $2.8B 163.29%
FY2021 $1.1B 42.65%
FY2020 $737.8M (16.12%)
FY2019 $879.6M (20.92%)
FY2018 $1.1B 44.71%
FY2017 $768.6M (7.08%)
FY2016 $827.1M 36.68%

Quarterly

Period EBITDA Change
Jun 2026 $608.7M 55.57%
Mar 2026 $391.3M —
Dec 2025 −$53.7M —
Sep 2025 $128.6M (40.55%)
42 more quarters

Against its own ten years

Low −$1.2B High $2.8B
Ten-year median $768.6M
Current reading's percentile 18

EBITDA against peers

What EBITDA is

EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.

Reported line item

The full definition of EBITDA →

More on ALB